SCHEMBL19631732

SCHEMBL19631732

C=C[C@]1(N2CCN(Cc3ccc(C#N)cc3)CC2)CCO[C@@H](C)C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 5/20 0.42
TSHR P16473 4/20 0.41
CYP2C9 P11712 3/20 0.41
CYP1A2 P05177 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2D6 P10635 7/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
CYP3A4 P08684 7/20 0.39
MAPK1 P28482 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP2C19 P33261 2/20 0.39
HSD17B10 Q99714 1/20 0.39
RAB9A P51151 1/20 0.39
KDM1A O60341 1/20 0.37
HIF1A Q16665 2/20 0.36
CCR2 P41597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21221623 0.81 USP2 (0.44) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL19631595 0.81 USP2 (0.44) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL21221671 0.81 USP2 (0.44) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL19631596 0.81 USP2 (0.44) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL22169639 0.75 SIGMAR1 (0.42) TSHRCYP2C9MEN1KMT2ACYP2D6
SCHEMBL19631660 0.71 USP2 (0.52) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL19631959 0.70 OPRM1 (0.45) CYP3A4HSD17B10
SCHEMBL20804360 0.69 KCNJ1 (0.66) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL28024576 0.69 KCNJ1 (0.66) USP2TSHRCYP2C9CYP1A2MEN1
SCHEMBL22169530 0.69 USP2 (0.41) USP2TSHRCYP2C9CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017198339-A1 TETRAHYDROPYRAN AND THIOPYRAN DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2017-11-23 WO disclosed